Patents by Inventor Violette SANCHEZ

Violette SANCHEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR USE IN TREATMENT OF CHLAMYDIA
    Publication number: 20250339506
    Abstract: This invention relates to compositions (e.g., vaccine compositions) which can be used to immunise against Chlamydia infections. The compositions comprise Chlamydia sp. antigens and antigen combinations which can be used to immunise against Chlamydia sp., used in the form of nucleic acids (e.g., mRNAs) encoding antigenic proteins or in the form of recombinant protein antigens.
    Type: Application
    Filed: February 5, 2025
    Publication date: November 6, 2025
    Inventors: Nadège ARNAUD BARBE, Leah COLE, Andreas KARLSSON, Violette SANCHEZ, Timothy TIBBITTS
  • Compositions for use in treatment of
    Patent number: 12263213
    Abstract: This invention relates to compositions (e.g., vaccine compositions) which can be used to immunise against Chlamydia infections. The compositions comprise Chlamydia sp. antigens and antigen combinations which can be used to immunise against Chlamydia sp., used in the form of nucleic acids (e.g., mRNAs) encoding antigenic proteins or in the form of recombinant protein antigens.
    Type: Grant
    Filed: March 4, 2024
    Date of Patent: April 1, 2025
    Assignee: SANOFI PASTEUR
    Inventors: Nadège Arnaud Barbe, Leah Cole, Andreas Karlsson, Violette Sanchez, Timothy Tibbitts
  • COMPOSITIONS FOR USE IN TREATMENT OF CHLAMYDIA
    Publication number: 20240299524
    Abstract: This invention relates to compositions (e.g., vaccine compositions) which can be used to immunise against Chlamydia infections. The compositions comprise Chlamydia sp. antigens and antigen combinations which can be used to immunise against Chlamydia sp., used in the form of nucleic acids (e.g., mRNAs) encoding antigenic proteins or in the form of recombinant protein antigens.
    Type: Application
    Filed: March 4, 2024
    Publication date: September 12, 2024
    Inventors: Nadège ARNAUD BARBE, Leah COLE, Andreas KARLSSON, Violette SANCHEZ, Timothy TIBBITTS